StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.23 on Tuesday. The stock has a market capitalization of $256,500.00, a P/E ratio of -0.02 and a beta of 2.14. Ampio Pharmaceuticals has a fifty-two week low of $0.14 and a fifty-two week high of $8.30. The business has a 50-day moving average of $0.98 and a 200-day moving average of $1.73.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share (EPS) for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Investing In Preferred Stock vs. Common Stock
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is Insider Trading? What You Can Learn from Insider Trading
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What Are Trending Stocks? Trending Stocks Explained
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
